1. Osteonecrosis of the Jaw (ONJ) andBisphosphonates Oncologic Drugs Advisory Committee March 4, 2005 Novartis Pharmaceuticals 2. Novartis Presentation ONJ Reported in Bisphosphonate-Treated…